NeoImmuneTech, Inc. (KOSDAQ: A950220)
Health Care · Biotechnology · US
₩1,892.00
-4.69% today · -42.8% 1Y
NeoImmuneTech, Inc. (KOSDAQ: A950220) operates in the Biotechnology industry within the Health Care sector. The company is valued at $139.14M.
Over the last twelve months the share price has lost 42.8%, trading between 1.11K and 4.45K.
Tweenvest scores NeoImmuneTech, Inc. across four factors: quality 38/100, value 39/100. Its strongest factor is value.
A950220 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $139.14M
- Revenue (TTM)
- $1.14M
- P/E
- —
- EPS
- -196.21
- Dividend yield
- —
- Beta (5Y)
- 0.54
- 52-week high
- ₩4,450.00
- 52-week low
- ₩1,115.00
- Avg volume (3M)
- —
- Shares outstanding
- 98.87M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnicoCell Biomed Co., Ltd.TWSE: 6794 | $142.50M | NT$71.60 | -9.25% |
| Cue Biopharma, Inc.NasdaqCM: CUE | $142.16M | $20.62 | +5.37% |
| Cloudbreak Pharma Inc.SEHK: 2592 | $140.32M | HK$— | — |
| 3billion, Inc.KOSDAQ: A394800 | $139.66M | ₩5,900.00 | -2.32% |
| Outlook Therapeutics, Inc.NasdaqCM: OTLK | $137.26M | $0.57 | +1.12% |
| Anavex Life Sciences Corp.NasdaqGS: AVXL | $137.19M | $1.48 | -1.99% |
| ALX Oncology Holdings Inc.NasdaqGS: ALXO | $135.46M | $1.00 | +2.08% |
| Armata Pharmaceuticals, Inc.NYSEAM: ARMP | $134.97M | $3.10 | -14.60% |
Figures last refreshed Oct 11, 2026.